These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 19080239)

  • 1. Equisetin is an anti-obesity candidate through targeting 11
    Xu Z; Liu D; Liu D; Ren X; Liu H; Qi G; Zhou Y; Wu C; Zhu K; Zou Z; Yuan J; Lin W; Guo P
    Acta Pharm Sin B; 2022 May; 12(5):2358-2373. PubMed ID: 35646525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice.
    Li H; Sheng J; Wang J; Gao H; Yu J; Ding G; Ding N; He W; Zha J
    Drug Des Devel Ther; 2021; 15():2309-2324. PubMed ID: 34103895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
    Liu J; Wang L; Zhang A; Di W; Zhang X; Wu L; Yu J; Zha J; Lv S; Cheng P; Hu M; Li Y; Qi H; Ding G; Zhong Y
    Endocr J; 2011; 58(3):199-209. PubMed ID: 21325744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adipose tissue endocrine mechanism of the prophylactic protective effect of pioglitazone in high-fat diet-induced insulin resistance.
    Gong Y; Li J; Li C; Mu Y; Xiao Y; Tian H; Pan C; Liu Y
    J Int Med Res; 2012; 40(4):1304-16. PubMed ID: 22971482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice.
    Wang SJ; Birtles S; de Schoolmeester J; Swales J; Moody G; Hislop D; O'Dowd J; Smith DM; Turnbull AV; Arch JR
    Diabetologia; 2006 Jun; 49(6):1333-7. PubMed ID: 16612591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of BVT.2733 and pioglitazone in the improvement of insulin resistance].
    Xie Y; Zhu T; Zhong Y; Liu J; Yu J; Zha JM; DI WJ; Ding GX
    Zhonghua Nei Ke Za Zhi; 2008 Nov; 47(11):938-41. PubMed ID: 19080239
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.